3-[3-(2-fluorophenyl)-1,2,4-oxadiazol-5-yl]propanoic acid, 95.0%, 250mg

Colonna HPLC NUCLEODUR® C8 Gravity 3 µm, 250 mm, 4.6 mm, 1 Pezzo(i)

2-chloro-4,7,8-trimethylquinoline, 95.0%, 1g

Bicyclo[4.2.0]octa-1,3,5-triene-3-methanol, 97%, 1g

5-Bromo-2-chlorobenzenethiol, 1g

2-Iodonaphthalene, 95.0%, 25g

2-Propyl-2 H -pyrazole-3-carboxylic acid, 95.0%, 5g

Colonna HPLC NUCLEODUR® C18 Piramide, 1 Pezzo(i)

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-N-(2,4-dimethoxybenzyl)-L-alanine, 95%, 500mg

1-(3,4-diethoxyphenyl)ethanone, 95.0%, 10g

Cyazofamid, 97%, 10g

tert-Butyl 6-formyl-3,4-dihydropyrrolo[1,2-a]pyrazine-2(1H)-carboxylate, 95.0%, 5g

3-(2-Methoxyphenyl)isoxazole-5-carboxylic acid, 95.0%, 500mg